Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

NETWORK 3OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 1

Conditions

Sarcoma 2Neoplasm Metastasis 1Colorectal Neoplasms 1Cervical Cancer Susceptible Population Classification 1

Interventions

High-Throughput Nucleotide Sequencing 2Base Sequence 2trametinib 1spartalizumab 1ribociclib 1palbociclib 1olaparib 1nilotinib 1glasdegib 1futibatinib 1durvalumab 1dabrafenib 1ceritinib 1capmatinib 1camrelizumab 1Radiotherapy 1Nivolumab 1Lapatinib 1Irinotecan 1Ipilimumab 1Environment 1Doxorubicin 1Docetaxel 1Cryosurgery 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Sarcoma × Base Sequence × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

Completed
24 enrolled
GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡